This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in ...

The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance ...

Two biotech stocks, Ligand Pharmaceuticals and United Therapeutics, are showing resilient action in Friday's stock market.

This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

Prasad contributed to an uncertain regulatory climate for gene therapy makers focused on rare conditions. Shares of many ...

Boris Nikolic’s career looked to be in tatters after his friendship with Jeffrey Epstein came to light in 2019. But he has ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going in 2026?

Azitra Inc. has secured up to $31.4 million in private financing as the company works to regain compliance with stock ...

Biotech skincare could offer a competitive edge when targeted and personalised skincare is concerned. Here is what you need ...